Skip to main content
Log in

Effects of antisense oligodeoxynucleotide to follicle-stimulating hormone receptor on the expression of proliferating cell nuclear antigen and vascular endothelial growth factor in primary culture cells derived from human ovarian mucinous cystadenocarcinoma

  • Published:
Journal of Huazhong University of Science and Technology [Medical Sciences] Aims and scope Submit manuscript

Summary

The effects of antisense oligodeoxynucleotide (antisense ODN) to follicle-stimulating hormone receptor (FSHR) and follicle-stimulating bormone (FSH) on the expression of proliferating cell nuclear antigen (PCNA) and vascular endothelial growth factor (VEGF) were studied in primary culture cells derived from human ovarian mucinous cystadenocarcinoma (OMC). The primary OMC cells were cultured with the enzyme digestion method, and the expression of pan Keratin protein and FSHR mRNA was detected for identification of the cells. OMC cells were co-cultured with antisense ODN, nonsense ODN and FSH with different concentrations for 48 h and 72 h. The expression of PCNA and VEGF was detected by using SP immunohistochemistry. Compared with that in the control group, the PCNA and VEGF expression was increased obviously in FSH groups (P<0.05 orP<0.01). while decreased significantly in antisense ODN groups (P<0.05 orP<0.01) and unchanged in nonsense ODN groups, respectively. Meanwhile, antisense ODN could antagonize the increased expression of PCNA and VEGF caused by FSH significantly (P<0.01). It was suggested that FSH might promote the development of OMC to some extent. Antisense ODN could inhibit the proliferative activity of OMC cells and the promoting proliferative activity enhanced by FSH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Wang J, Lin L, Parkash V Pet al. Quantitative analysis of follicle-stimulating hormone receptor in ovarian epithelial tumors: a novel approach to explain the field effect of ovarian cancer development in secondary mullerian systems. Int J Cancer, 2003, 103: 328–334

    Article  PubMed  CAS  Google Scholar 

  2. Syed V, Ulinski G, Mok S Cet al. Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells. Cancer Res, 2001, 61: 6768–6776

    PubMed  CAS  Google Scholar 

  3. Feng Y J, Zhang X Y, Ge B Qet al. The effects of gonadotrophin on the cell proliferation of ovarian epithelial cancer. Chin J Obstet Gynecol (Chinese), 1996, 3: 166

    Google Scholar 

  4. Li M E, Peng Z L, Zhang P H. The expression and clinical significance of PCNA in ovarian serosity tumors. J Shanxi Med Coll (Chinese), 2002, 4: 101–102

    Google Scholar 

  5. Zhang N. The expression of VEGF and PCNA in ovarian epithelial tumors. J Diag Pathol (Chinese), 2004, 10: 340–342

    Google Scholar 

  6. O'Shaughnessy P J, Dudjey K, Rajapaksha W R. Expression of follicle stimulating hormone-receptor mRNA during gonadal development. Mol Cell Endocrinol, 1996, 125 (122): 169–175

    Article  PubMed  Google Scholar 

  7. Takahshi H, Strutton GM, Parsons P Cet al. Determination of proliferating fractins in malignant melanomas by anti-PCNA/cyclin monoclonal antibody. Histopathology, 1991, 18: 221

    Article  Google Scholar 

  8. Jiang J, Wang Y, Wang R. The relationship between the expression of PCNA and the prognosis of ovarian epithelial cancer. Chin J Exp Diag (Chinese). 1998, 6: 104–105

    Google Scholar 

  9. Kraemer S, Jaeger W H, Lang N. Growth regulation effects of gonadotropin induced steroidogenic response in human ovarian cancer. Anticancer Res, 2001, 21: 2005–2010

    PubMed  CAS  Google Scholar 

  10. Zheng W, Lu J, Luo Fet al. Ovarian epithelial tumor growth promotion by follicle-stumilating hormone and inhibition of the effect by luteinzing hormone. Gynecol Oncol, 2000, 76: 80–88

    Article  PubMed  CAS  Google Scholar 

  11. Zheng W, Magid M S, Kramer E Eet al. Follicle-stimulating hormone recptor is expressed in human ovarian surface epithelium and fallopian tube. AmJ Pathol, 1996, 148: 47–53

    CAS  Google Scholar 

  12. Shen Z, Fang M. The biochemistry characteristics of FSHR and its expression and regulation. Modern J Obstet Gynecol Advanced (Chinese), 2004, 13: 137–139

    Google Scholar 

  13. Zhu C, Wang Y, Nixon M Det al. Antisense oligode-oxynucleotide inhibits expression of recombinant porcine follicle-stimulating hormone receptor. Mol Reprod Dev. 2003, 65: 188–193

    Article  PubMed  CAS  Google Scholar 

  14. Zhu C, Xiong Z, Xiao H. The effects of antisense oligodeoxynucleotide on the expression of recombinant porcine follicle-stimulating hormone receptor. National J Androl (Chinesc), 2000, 3: 146–149

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

LI Shuang, female, born in 1971. Doctor in charge

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shuang, L., Hefang, L., Ling, W. et al. Effects of antisense oligodeoxynucleotide to follicle-stimulating hormone receptor on the expression of proliferating cell nuclear antigen and vascular endothelial growth factor in primary culture cells derived from human ovarian mucinous cystadenocarcinoma. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 26, 111–115 (2006). https://doi.org/10.1007/BF02828054

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02828054

Key words

Navigation